Ramirez-Velandia Felipe, Filo Jean, Enriquez-Marulanda Alejandro, Fodor Thomas B, Sconzo Daniel, Young Michael, Muram Sandeep, Granstein Justin H, Shutran Max, Taussky Philipp, Ogilvy Christopher S
1Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston; and.
2Harvard Medical School, Boston, Massachusetts.
J Neurosurg. 2024 Aug 16;142(1):78-87. doi: 10.3171/2024.5.JNS24476. Print 2025 Jan 1.
Thromboembolic (TE) events are among the most feared complications after flow diversion (FD) and have been reported to occur even with adequate dual antiplatelet therapy. Herein, the authors characterize thrombotic and embolic events that developed after FD, focusing on the morbidity of each of these events and the predisposing factors associated with their development.
A retrospective analysis of aneurysms treated with FD at a single institution in the US between 2013 and 2023 was performed. The authors documented the emergence of intraprocedural and postoperative TE events. A survival analysis and a Cox regression model was conducted to identify predictors associated with these events.
The authors included 651 procedures performed in 591 patients to treat 746 aneurysms. TE events occurred in 38 of the procedures performed (5.8%), causing permanent deficit in 20 patients and death in 4 patients. Eleven cases presented with acute stent thrombosis, 11 with large-vessel occlusion, and 9 with perforator strokes. At a median follow-up of 9.5 months, 73.0% of patients with an ischemic event had a modified Rankin Scale score ≤ 2. Three of the deaths were secondary to occlusion at the basilar trunk and vertebral artery. In patients with TE events in the anterior circulation, 7 of 11 patients with middle cerebral artery occlusion and 9 of 12 patients with internal carotid artery occlusion achieved independence. Time-to-event Cox regression analysis demonstrated that TE events were more frequent in patients exhibiting aspirin resistance (hazard ratio 2.66; 95% CI 1.10-6.70).
TE events after FD result from multiple factors, including age, aneurysm characteristics, aneurysm location, antiplatelet resistance, and procedural factors. In our cohort, we found the highest morbidity for patients with TE events presenting with large-vessel occlusion at the middle cerebral artery, and vertebrobasilar system.
血栓栓塞(TE)事件是血流导向(FD)术后最令人担忧的并发症之一,据报道,即使采用充分的双联抗血小板治疗也会发生。在此,作者对FD术后发生的血栓形成和栓塞事件进行了特征描述,重点关注这些事件各自的发病率以及与其发生相关的诱发因素。
对2013年至2023年在美国一家机构接受FD治疗的动脉瘤进行回顾性分析。作者记录了术中及术后TE事件的发生情况。进行生存分析和Cox回归模型以确定与这些事件相关的预测因素。
作者纳入了591例患者接受的651次手术,以治疗746个动脉瘤。在38次手术(5.8%)中发生了TE事件,导致20例患者出现永久性神经功能缺损,4例患者死亡。11例表现为急性支架血栓形成,11例为大血管闭塞,9例为穿支卒中。在中位随访9.5个月时,73.0%发生缺血事件的患者改良Rankin量表评分≤2。3例死亡继发于基底动脉干和椎动脉闭塞。在前循环发生TE事件的患者中,大脑中动脉闭塞的11例患者中有7例、颈内动脉闭塞的12例患者中有9例实现了独立生活。事件发生时间Cox回归分析表明,阿司匹林抵抗的患者发生TE事件更为频繁(风险比2.66;95%CI 1.10 - 6.70)。
FD术后的TE事件由多种因素引起,包括年龄(应为“年龄、动脉瘤特征、动脉瘤位置、抗血小板抵抗和手术因素”,原文此处表述有误)、动脉瘤特征、动脉瘤位置、抗血小板抵抗和手术因素。在我们的队列中,我们发现大脑中动脉和椎基底系统出现大血管闭塞的TE事件患者发病率最高。